An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.
about
Optimal management of genital herpes: current perspectivesThe challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineRepertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein DAn attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeCurrent status and prospects for development of an HSV vaccineProspects and perspectives for development of a vaccine against herpes simplex virus infections.Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinologyTopical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengeIdentification of systemic immune response markers through metabolomic profiling of plasma from calves given an intra-nasally delivered respiratory vaccine.Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomesAntibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensGenerating protective immunity against genital herpesDistribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseNasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.Animal models of herpes simplex virus immunity and pathogenesis.Overview of Vaccine Adjuvants: Introduction, History, and Current Status.Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral ReseA trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial.Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.Differential expression of mRNA and miRNA in guinea pigs following infection with HSV2v.Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.Attenuated Phenotype and Immunogenic Characteristics of a Mutated Herpes Simplex Virus 1 Strain in the Rhesus Macaque.Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.Clinical management of herpes simplex virus infections: past, present, and future
P2860
Q26746041-9BBE6CCA-9BB8-4B28-8041-0631EFF5F607Q27021292-F5526BAF-3D88-4BB4-B04A-438EEED2B4A1Q33900262-30175150-D0C5-4330-898E-9D8D26E8A7B1Q33916162-5EC4DD70-0F2B-4863-86D1-10B49BB8D7A1Q33931016-C7FE6EE2-28D2-462E-A145-43D46B32C495Q34431547-0B9F7A64-45B1-40C2-AABF-07402629A72EQ34611897-C9F54892-0E62-4D07-94CB-52ECB939C730Q34992660-1D94C220-4028-4844-A49B-7414584E8A9BQ35082519-AEC24334-3B47-4CEB-A69F-AA1CEDF306CBQ35559725-31B450B7-5119-4190-A60A-9CE9F4837B4AQ35869527-E09985BB-6F4B-41C6-B6CE-9FA23E7AD03DQ35914367-803CD6FD-7C35-4DC5-8FDB-28C0AF39474CQ37283993-8A872C43-FD38-465E-989D-5DCFC8E7639BQ37523020-D59F80C2-744D-4875-A772-71362C0A89CFQ37531713-41CF734B-C281-4621-AF97-34436BEBB746Q37547107-BF02886E-9F1F-4908-A233-ECDB2B0DA244Q37611796-F94D031C-3A92-4A45-A046-78178F591522Q38212516-BD234A62-A667-4EC0-A7E7-A14E430A7E02Q38241377-C3FD0F0C-B523-4122-B496-043775FECB68Q38243160-F50D6B71-0407-40B9-BF2D-FBFF1C911607Q38267269-E27CE9CF-283F-4C1F-8D74-D006D252E53BQ38813523-0C2C6D5E-5DD0-465D-BE85-47E61C753C96Q38947443-17F1297E-CEDA-4A47-9243-FDEE3B8B36D2Q40210971-483D710C-99F2-417A-B456-9CC523D06879Q40280300-F24BEDC6-22D6-4DE3-80E5-CF0011308556Q41120363-4E960503-D394-47CF-A2EC-18DC0C2A7503Q41672100-1E74D141-9732-437F-AADC-26333A276045Q41928445-6729C98A-7F48-4ADA-89E9-A362B28CA48FQ45325692-1AB39198-3090-4C4A-B230-BE1D6FC7B500Q55284064-E21C22D1-C35C-40A1-B0BC-29562F26A827Q55406946-3CA35762-09E6-4AF9-8C0F-D6C3D8232468Q59133817-74BFEA78-BE0E-45EF-AD89-DB54A0529F36
P2860
An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@ast
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@en
type
label
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@ast
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@en
prefLabel
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@ast
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@en
P2093
P2860
P356
P1433
P1476
An adjuvanted herpes simplex v ...... peutic vaccine in Guinea pigs.
@en
P2093
Alexander Lee
Amy Lundberg
Ana Kazimirova
Danielle Garvie
David I Bernstein
Deborah Long
Fernando J Bravo
Mojca Skoberne
Rhonda Cardin
Shane Larson
P2860
P304
P356
10.1128/JVI.02745-12
P407
P577
2013-01-30T00:00:00Z